1. Home
  2. PRGO

PRGO

Perrigo Company plc

Logo Perrigo Company plc

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 9:39am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Founded: 1887 Country:
Ireland
Ireland
Employees: N/A City: DUBLIN 2
Market Cap: 4.3B IPO Year: 1991
Target Price: $40.00 AVG Volume (30 days): 2.0M
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: 3.52% Dividend Payout Frequency: Quarterly
EPS: -0.09 EPS Growth: N/A
52 Week Low/High: $25.77 - $40.28 Next Earning Date: 05-07-2024
Revenue: $4,655,600,000 Revenue Growth: 4.58%
Revenue Growth (this year): 1.94% Revenue Growth (next year): 4.57%

Share on Social Networks: